JAC Advance Access originally published online on January 9, 2007
Journal of Antimicrobial Chemotherapy 2007 59(3):433-440; doi:10.1093/jac/dkl490
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A novel ex vivo skin model to study the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment in different growth phases
1 Leiden University Medical Centre, Skin Research Laboratory, PO Box 9600, 2300 RC Leiden, The Netherlands 2 University of Leiden, Leiden/Amsterdam Centre for Drugs Research, Leiden, The Netherlands 3 PhotoBioChem NV, Leiden, The Netherlands
* Corresponding author. Tel: +31-71-5269376 / +31-71-5269360; Fax: +31-71-5268286; E-mail: G.M.T.Smijs{at}LUMC.nl
Received 19 July 2006; returned 14 October 2006; revised 20 October 2006; accepted 2 November 2006
| Abstract |
|---|
|
|
|---|
Background: Dermatophytes are fungi that can cause infections of skin, hair and nails because of their ability to feed on keratin. Superficial mycoses are among the most prevalent infectious diseases worldwide. Two important restrictions of current therapeutic options are the recurrence of the infection and prolonged treatment. This is especially true for infections caused by Trichophyton rubrum, a widely distributed dermatophyte. The application of photosensitizers for treatment of fungal infections is, within the field of photodynamic treatment (PDT), relatively new. Recently, we demonstrated that the porphyrins 5,10,15-tris(4-methylpyridinium)-20-phenyl-[21H,23H]-porphine trichloride (Sylsens B) and deuteroporphyrin monomethylester (DP mme) were excellent photosensitizers towards T. rubrum when using red light.
Objectives and methods: To evaluate the photodynamic effectiveness of the porphyrins in a situation that mimics the clinical situation, we developed an ex vivo model using human stratum corneum. This model offers the possibility of applying PDT at different time points during the germination and subsequent development of T. rubrum microconidia. The model was used for two different incubation media, Dulbecco's modified Eagle medium (DMEM) and distilled water.
Results and conclusions: We demonstrated that the PDT susceptibility of T. rubrum depended on the time of PDT application after spore inoculation. A decrease in susceptibility was observed with increasing time of PDT application for both photosensitizers in DMEM. Changing the incubation medium to distilled water resulted in an increased fungicidal effect for Sylsens B and in a decreased effect for DP mme. We conclude that T. rubrum is susceptible to PDT in a situation that mimics the clinical situation. The fungicidal effect of PDT on fungal spores is of particular importance.
Keywords: ex vivo model , stratum corneum , porphyrins , tinea , microconidia
| Introduction |
|---|
|
|
|---|
Dermatophytes are fungi that can cause infections of the skin, hair and nails, in part because of their ability to utilize keratin. The cutaneous infections they cause (also called tinea) are among the most common infections in humans worldwide.1 In the USA, 10% of the population has cutaneous fungal infections at any given time, and at least 40% will acquire this skin condition at some time in their life.2 The dermatophyte Trichophyton rubrum causes the most common cutaneous infection in humans,3,4 which can be very persistent.5
Two of the most important restrictions limiting the usefulness of common therapeutic options are the relatively high likelihood of recurrence of the infection and the need for prolonged treatment.6 Many current antifungal agents, such as azoles, have a fungistatic effect (a delay in growth) rather than a fungicidal effect (a complete inactivation of both fungal conidia and hyphae). Fungal conidia appear to be less susceptible to the antifungal agents than the hyphae.7,8 In case of widespread, more inflammatory or persistent dermatophytoses, systemic treatment is necessary. However, when using systemic therapy one should be aware of the potential risks of drug interactions and adverse effects, such as hepatotoxicity or general drug reactions. In addition, azole resistance appears to be emerging as a serious problem in patients treated for yeast infections.9
Photodynamic treatment (PDT) refers to the use of light-activated agents called photosensitizers.10 Upon irradiation with light of an appropriate wavelength, photosensitizers can initiate a photochemical reaction resulting in the production of reactive oxygen species, namely singlet oxygen (1O2) and superoxide anion radical (O2), which can react with various cellular components. The sequence of these events is known as the photodynamic effect and can result not only in a selective tissue injury, but also in the elimination of different kinds of pathogens.11 The use of PDT for fungal infections is a new and promising approach.12
Recently, we have demonstrated that the porphyrins 5,10,15-tris(4-methylpyridinium)-20-phenyl-[21H,23H]-porphine trichloride (Sylsens B; Figure 1a) and deuteroporphyrin monomethylester (DP mme; Figure 1b) are excellent photosensitizers to treat T. rubrum in suspension when red light is used to activate them.13 A single PDT in vitro was sufficient to achieve a 100% fungicidal effect, using either Sylsens B or DP mme
.
|
To evaluate the photodynamic activity of these two porphyrin photosensitizers under conditions that mimic the clinical situation of tinea infections, we developed an ex vivo model using human stratum corneum (SC). This ex vivo model offers the possibility of applying PDT at different time points during the germination process of T. rubrum microconidia on human SC and also during the subsequent development of germ tubes and fungal hyphae. We have used the model to investigate the efficacy of the porphyrin photosensitizers Sylsens B and DP mme towards T. rubrum. The susceptibility of T. rubrum to PDT was investigated in different growth phases of the fungus grown under two different conditions. Because of the importance of a single treatment for tinea infections, special attention has been paid to the fungicidal effect of PDT. Information on the susceptibility of different growth phases to PDT can be of great importance for the development of a treatment strategy that would lead to inactivation of both fungal spores and hyphae. Such a treatment would prevent the recurrence of the infection and reduce the number of treatments. The growth of T. rubrum on human SC in the ex vivo model was visually investigated before and after PDT using different microscopic techniques.
| Materials and methods |
|---|
|
|
|---|
Materials
Trichophyton rubrum was purchased from the Centraalbureau voor Schimmelcultures (CBS; strain no: 304.60), Utrecht, The Netherlands. For the preparation of a microconidia suspension, T. rubrum cultures were grown on Sabouraud dextrose agar (Sigma-Aldrich Chemie, Germany) at room temperature. The photosensitizers Sylsens B (mol. wt: 769.16 g/mol) and DP mme (mol. wt: 524.61 g/mol) were synthesized by the Department of Bio-Organic Photochemistry, Leiden University, The Netherlands (purity determined by NMR was more than 99.5%) and kindly provided to us. Polyethyleneglycol was obtained from Genfarma B.V. (Maarssen, The Netherlands) and trypsin was obtained from Sigma (Zwijndrecht, The Netherlands), while all other chemicals were purchased from J. T. Baker (Deventer, The Netherlands). The following solvents were used: 50 mM sodium phosphate buffer pH 7.4 for Sylsens B and polyethyleneglycol/ethanol/water (3:2:5) for DP mme. Stock solutions of the photosensitizers (4.8 mM) were freshly made for each new experiment.
Preparation of microconidia suspensions
The protocol to obtain a suspension of microconidia produced by T. rubrum grown on Sabouraud dextrose agar was based on the method described by Zurita and Hay14 with two modifications. A 0.01% Tween 80 solution in sterile water was used instead of phosphate-buffered saline and a 7 µm Millipore filter was used instead of a 8 µm Nucleopore filter. The protocol was as follows: To a 14-day-old culture, 810 mL of a 0.01% Tween 80 solution was added. The surface was brushed with a glass rod and the resulting suspension filtered over a 7 µm diameter filter (Millipore). The filtrate was centrifuged at 3400 g (10°C) and the resulting pellet was washed with sterile water and suspended again in sterile water in a total volume of 24 mL (1040 x 106 cfu/mL). The obtained microconidia suspensions were stored in liquid nitrogen for no longer than 6 months. Counting the number of colony-forming units on malt extract agar (MEA) dishes was used as a viability check. Identification of the isolated spores as microconidia was performed by the CBS.
Preparation of the human stratum corneum (SC)
Abdomen or mammae skin was obtained from a local hospital after cosmetic surgery. After removal of the fat tissue, the skin was cleaned with distilled water and dermatomed to a thickness of approximately 250 µm using a Padgett Electro Dermatome Model B (Kansas City, USA). The dermatomed skin was incubated at the dermal side with a 0.1% trypsin solution in phosphate buffered saline of pH 7.4 (4°C) overnight. After 1 h at 37°C the SC was removed manually. The obtained SC was air-dried for 24 h and kept under nitrogen over silica gel for no longer than 3 months.
A polycarbonate membrane filter, 25 mm in diameter and with a pore size of 2 µm (Omnilabo, Breda, The Netherlands), was placed in the central part of a 3 cm culture dish (Greiner, Alphen aan den Rijn, The Netherlands) filled with 5 mL of MEA. A circular piece of human SC with a diameter of 1 cm was subsequently placed on the membrane filter and both were gently brushed with a paintbrush dipped in 70% ethanol. A microconidia suspension was diluted to 1000 cfu/mL and 15 µL inoculated on the circular piece of human SC in a dish which was then placed in an incubator at 28°C. At 8, 24, 48 and 72 h after spore inoculation, PDT was applied using either Sylsens B or DP mme. The conditions of the ex vivo model are such that germination of the microconidia can be detected microscopically (Zeiss Axiovert 25) at 72 h after their inoculation. This implies that when PDT is applied at 72 h after spore inoculation fungal hyphae are treated. The test conditions were chosen to resemble those used in the in vitro experiments,13 except for the duration of the incubation and the concentration of the porphyrins.
A schematic outline of the ex vivo model, including the PDT stadium, is provided in Figure 2.
|
Light source
Illuminations were performed with a lamp from MASSIVE (no. 74900/21), 1 x max 500 W-230 V-R7s, IP 44. To avoid heating of the samples during illumination, a 5 cm water filter absorbing infrared light was used. Light intensity was measured with an IL1400A photometer equipped with a SEL033/F/U detector (International Light, Newburyport, MA, USA). A red cutoff filter at 600 nm was used to obtain the red part of the spectrum of the light produced by the lamp. The light emitted by the lamp had a wavelength range of 580870 nm. The light intensity at the level of the infected human SC was 30 mW/cm2.
At 8, 24, 48 or 72 h after spore inoculation, the membrane filter with SC containing spore inoculates was transferred from the MEA dish to a 3 cm culture dish filled with 1035 µL of incubation medium. The incubation medium contained either 1 mL of distilled water (pH 5.2) or 1 mL of DMEM (GibcoBRL, UK) at pH 7.4 supplemented with fetal calf serum (FCS; GibcoBRL, UK) and 35 µL of a photosensitizer solution. Final photosensitizer concentrations were 80 and 160 µM. To optimize the contact of the inoculated fungus with the incubation medium, the membrane filter with the SC was turned upside down during the incubation period of 2 h (see Figure 2c). The incubation was performed under continuous shaking conditions (Heidolph Shaker, unimax 2010). Shortly before the illumination period, the membrane filter containing the SC was turned back (Figure 2d). In all cases, the illumination time was 1 h using a light flux rate of 30 mW/cm2 (Figure 2e). This corresponds to a light dose of 108 J/cm2. After the illumination the membrane filter with the SC was transferred to a fresh MEA dish (Figure 2f), placed in an incubator at 28°C, and fungal growth was followed for several weeks. Dark controls were included, i.e. the same procedure was carried out except that the inoculated microconidia on human skin were treated with solvent or photosensitizer in the dark. In the light controls, the microconidia were treated with solvent in the presence of light. The efficacy of the treatment was expressed as a relative frequency of complete inactivation of fungal growth detected at day 8 after spore inoculation. To assess this a Zeiss Axiovert 25 microscope was used. If at day 8 by visual inspection no re-growth could be observed, a complete inactivation of spores and hyphae as a result of PDT was established. The treatment effect was followed for a period of several months. Every experiment contained 4 to 6 duplicates of all conditions and the experiments were repeated at least three times.
After the PDT (applied at 72 h after spore inoculation or dark treatment) the SC was placed on an object glass, washed with water, covered with a glass coverslip and examined with a Leica DM 5000 microscope equipped with differential interference contrast (DIC) optics and a digital camera (Leica DFC300FX R2 digital colour cam set). A HCX PL FLUOTAR 40 x /0.75 Ph2.objective and a HCX PL FLUOTAR 63 x /1.25 oil immersion objective were used and fluorescence images were taken using a filter cube violet + blue (H3, excitation filter BP 420490). The pictures were taken directly after treatment with 160 µM Sylsens B in the dark, after an unsuccessful PDT with 80 µM Sylsens B and after a successful PDT with 160 µM Sylsens B, when a fungicidal effect was detected. Pictures of untreated fungus, at 72 h after spore inoculation, were taken as well.
| Results |
|---|
|
|
|---|
Changing the incubation medium from DMEM to distilled water resulted in an increased PDT efficacy for Sylsens B
The results obtained with Sylsens B are provided in Table 1. When incubating in DMEM, we found that 8 h after spore inoculation, application of PDT with either 80 or 160 µM Sylsens B resulted in a complete inactivation of the spores. At 24 h after spore inoculation under the same conditions, a fungicidal effect was obtained in 50% of the cases, while in the remaining cases only a delay in growth was observed. However, the application of PDT more than 24 h after the spore inoculation did not result in a fungicidal effect. In those cases, a growth delay of 12 days was obtained, depending on the Sylsens B concentration used. Incubation in distilled water at pH 5.2 resulted in a considerably higher number of fungicidal effects compared with incubation in DMEM. When 160 µM Sylsens B was used we obtained a fungicidal effect not only after 8 h, but also after 24 and 48 h. At these time points the fungicidal effect was almost 100%. In addition, even at 72 h after spore inoculation, when fungal hyphae were treated, we found a high percentage (65%) with complete fungus inactivation. In the experiments with DMEM the light controls resulted in 1015 cfu for every time point at 8 days after spore inoculation. Very similar results were obtained in the dark controls with both Sylsens B concentrations. In the case of distilled water, the light controls developed 1015 cfu for every time point at 8 days after spore inoculation and the dark controls 512 cfu.
|
Changing the incubation medium from DMEM to distilled water caused a decreased PDT efficacy for DP mme
As far as DP mme is concerned (Table 2), the results resembled those obtained with Sylsens B in DMEM (Table 1): a complete inactivation of the spores 8 h after spore inoculation and a fungicidal effect of 5085% when PDT was applied at 24 h after spore inoculation. When applying PDT at 48 and 72 h after inoculation, the treatment resulted only in a delay of growth, and no fungicidal effect was observed. However, in contrast to the results obtained with Sylsens B, the change of DMEM to water resulted in decreased efficacy. Only a small percentage of fungicidal effects could be obtained at the 8 h time point and no fungicidal effect was present at 24 h after spore inoculation or later. Both the light and dark controls in DMEM developed 1015 cfu at day 8. In the case of the water medium, the light controls contained 1015 cfu at each time point and the dark controls 512 cfu.
|
Sylsens B is localized on the fungal wall after dark treatment and inside the fungal hyphae after successful PDT
The DIC and fluorescence microscopy images shown in Figure 3 were made at different locations in the same preparation. In this way we could select the most representative examples for both microscopic techniques.
|
Microscopic preparations of T. rubrum in the ex vivo model were made for four different conditions. Firstly, T. rubrum was visualized at 72 h after spore inoculation (see Figure 3a and b). It can be seen from Figure 3(b) that under the selected fluorescence microscopic conditions the fungus showed a green coloured autofluorescence. The images shown in Figure 3 (c and d), were taken from T. rubrum directly after the treatment with 160 µM Sylsens B in the dark at 72 h after spore inoculation. Both the DIC (Figure 3c) and the fluorescence images (Figure 3d) show that Sylsens B, represented by the red colour in the DIC images and the red/orange fluorescence in the fluorescence images, is localized on the fungal wall (see arrow points and inlays). Figure 3(e) (DIC) and Figure 3(f) (fluorescence) show images of the fungus after unsuccessful PDT using 80 µM Sylsens B, applied 72 h after spore inoculation. Again the arrows point (see inlays as well) to the localization of Sylsens B on the fungal cell wall.
Figure 3 (g and h) shows images taken from T. rubrum after a successful PDT with 160 µM Sylsens B, applied at 72 h after spore inoculation, when a fungicidal effect could be detected. Interestingly, the fluorescence image shown in Figure 3(h), taken at this stage shows that the red fluorescence of Sylsens B is present inside the fungal hyphae. The arrows in both the DIC and fluorescence images from this stage point to fungal hyphae filled with Sylsens B.
| Discussion |
|---|
|
|
|---|
In this study we developed an ex vivo model in order to investigate the conditions and evaluate the efficacy of a PDT of the dermatophyte T. rubrum. Since our model offers the possibility of evaluating the therapeutic effect in different phases of the germination process, it may contribute to a better understanding of the way in which the therapy affects these individual growth phases. This is important since up to now only very few studies were concerned with the therapeutic fungicidal effects on different inoculates.15,16 Recently, Seebacher7 compared the efficiency of modern antifungal agents on both proliferating fungal strains and fungal spores.
Using our novel model, it has become clear that microconidia from T. rubrum attached to human SC can be completely inactivated by the porphyrin photosensitizer Sylsens B when PDT is applied at an early growth stage (8 h after spore inoculation). This result is in agreement with previous in vitro results where microconidia were used in suspension.13 However, in these in vitro experiments, using the same light conditions, a much lower concentration (1 µM) of Sylsens B could be used for effective treatment. We suggest that the adherence of the microconidia to a substrate, like the SC in our ex vivo model, may influence the PDT susceptibility. This situation was different in our in vitro experiments when we worked with the suspensions and where the attachment to a surface did not play a role. Moreover, from our experiments it has become clear that the photosensitizer concentration is not the only factor playing a part in achieving a fungicidal effect. The occurrence of the fungicidal effect was strongly affected by the medium in which photosensitizers were applied. Using distilled water in combination with Sylsens B resulted in a high percentage of complete fungal kill in every tested growth phase. From this observation we can also conclude that PDT can damage both the microconidia and fungal hyphae attached to SC. This is an important observation, since the pathogenesis is determined by the factors that control the fungal adherence, namely mechanical factors and production of the enzyme keratinase.14,17 We propose that some local factors, adjusted by using water as an incubation medium, could be responsible for the remarkable difference in PDT efficacy. The pH of the water was 5.2, which was considerably lower than that of DMEM (pH 7.4). A lower pH may, in the case of Sylsens B, promote a selective binding to the fungus rather than to the SC. It is known that the isoelectric point of human skin is approaching pH 5,18 which means that when an incubation pH of 5.2 is used the SC will be, at least partly, positively charged. Furthermore, we have found the first indications that the surface potential of both the fungal microconidia and hyphae is negative between pH 3.5 and 9.0. We therefore speculate that there will be a pH range where it is possible to promote a selective binding of the cationic photosensitizer, Sylsens B, to the fungus rather than to the skin. This reasoning can also explain the result we obtained with DP mme. This porphyrin is negatively charged at both pH 7.4 and 5.2. However, in the latter case there may also be a substantial amount of D mme present that contains no net molecular charge due to the protonation of the carboxylic acid group (R. N. van der Haas, personal communication). We found that when using DP mme and DMEM the results resembled those obtained with Sylsens B. However, in the case of DP mme, changing the incubation medium from DMEM to distilled water did not improve the efficacy but decreased it instead. This result can be explained as follows: when incubating at pH 5.2 there will be a selective binding of the DP mme part that is negatively charged to the SC rather than to the fungus because of the positive charges present in the SC. This will, of course, decrease the efficacy of the treatment. The neutral part of DP mme will display an increased affinity towards the hydrophobic SC since the molecule has a more lipophilic character due to the protonated carboxylic acid group. It is also of importance that the aggregation of DP mme will increase at a pH of 5.2. Because of the complexity of the factors that may be of importance in the PDT effectiveness, we are currently focusing on the mechanisms playing a role in the interactions between the photosensitizers and the surface of the targeted fungi. This investigation concerns research into the factors that can be of importance, like the ionic strength and pH of the surrounding medium, the surface potential of both microconidia and fungal hyphae, and the photophysical and photochemical properties of both photosensitizers.
The fluorescence and DIC images made from the different stages clearly illustrate that Sylsens B is localized on the fungal wall in the case of the dark controls and unsuccessful light treatments (Figure 3c, d, e and f). However, Figure 3 (g and f) shows a localization of the photosensitizer inside the fungal wall. Since the fungus was successfully treated with Sylsens B, a disruption of the fungal wall after PDT could be responsible for the penetration of Sylsens B inside the fungus. It can be concluded that in a situation that mimics the clinical situation, as represented by our ex vivo model, T. rubrum (both fungal spores and hyphae) can be successfully treated with PDT using 160 µM Sylsens B and a light dose of 108 J/cm2 (red light). The susceptibility of T. rubrum to PDT is clearly dependent on the time at which the treatment is performed. Application of the PDT at an increasing time after spore inoculation seems to decrease the susceptibility of the fungus to the treatment. This observation is in contrast with the experiences with regular antifungal therapeutics.19 It should be emphasized also that the inactivation of the spores by PDT under the given circumstances seems to be successful. This in contrast to many current therapeutic treatments where the spores are especially difficult to treat.7,8 These non-responsive spores may remain in the skin where they can initiate a relapse of the infection. Our current research focuses on improving the PDT efficacy in the phases where fungal hyphae are treated. One may expect that the factors that influence the attachment of photosensitizer to fungal wall will be of essential importance in these growth phases. Also, the factors involved in the attachment of the fungus to the SC may be of importance. Controlling these factors is an essential condition for reaching maximal fungicidal effect.
| Transparency declarations |
|---|
|
|
|---|
None to declare.
| Acknowledgements |
|---|
This work was supported by the Dutch Technology foundation (STW project LKG 6432). We thank Dr Richard van der Haas from the University of Amsterdam (Laboratory of synthetic Organic Chemistry) and Dr Rob van der Steen from Buchem Holding BV (Lieren, The Netherlands) for the synthesis of the various porphyrin photosensitizers and for their valuable advice.
| References |
|---|
|
|
|---|
1 Aly R. (1994) Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol 31:S21S25.[Web of Science][Medline]
2 Rudolf A. (1995) Superficial Fungal Infections. In Kalter DC, Sanders CVS, Nesbitt LT (Eds.). Skin and Infections(Williams & Wilkins, Baltimore, MD) pp. 157161.
3 Zaias N, Glick B, Rebell G. (1996) Diagnosing and treating onychomycosis. J Fam Pract 42:51318.[Web of Science][Medline]
4 Rippon JW. (1985) The changing epidemiology and emerging patterns of dermatophyte species. Curr Top Med Mycol 1:20834.[Medline]
5 Omero C, Dror Y, Freeman A. (2004) Trichoderma spp. antagonism to the dermatophyte Trichophyton rubrum: implications in treatment of onychomycosis. Mycopathologia 158:17380.[CrossRef][Web of Science][Medline]
6 Vera JR and Cervera LA. (2001) Advantages and disadvantages of topical antifungal agents. Rev Esp Quimioter 14:23237.[Medline]
7 Seebacher C. (2003) Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis. Mycoses 46:50610.[CrossRef][Web of Science][Medline]
8
Fernandez-Torres B, Inza I, Guarro J. (2003) Comparison of in vitro antifungal susceptibilities of conidia and hyphae of dermatophytes with thick-wall macroconidia. Antimicrob Agents Chemother 47:33712.
9 Pinjon E, Moran GP, Coleman DC, Sullivan DJ. (2005) Azole susceptibility and resistance in. Candida dubliniensis. Biochem Soc Trans 33:121014.
10 Marcus SL and McIntyre WR. (2002) Photodynamic therapy systems and applications. Expert Opin Emerg Drugs 7:32134.[CrossRef][Medline]
11 Demidova TN and Hamblin MR. (2004) Photodynamic therapy targeted to pathogens. Int J Immunopathol Pharmacol 17:24554.[Web of Science][Medline]
12
Lambrechts SA, Aalders MC, Van Marle J. (2005) Mechanistic study of the photodynamic inactivation of Candida albicans by a cationic porphyrin. Antimicrob Agents Chemother 49:202634.
13 Smijs TG, van der Haas RN, Lugtenburg J, et al. (2004) Photodynamic treatment of the dermatophyte Trichophyton rubrum and its microconidia with porphyrin photosensitizers. Photochem Photobiol 80:197202.[CrossRef][Web of Science][Medline]
14 Zurita J and Hay RJ. (1987) Adherence of dermatophyte microconidia and arthroconidia to human keratinocytes in vitro. J Invest Dermatol 89:52934.[CrossRef][Web of Science][Medline]
15 Rashid A. (1996) New mechanisms of action with fungicidal antifungals. Br J Dermatol 134:Suppl_4616.[CrossRef][Web of Science][Medline]
16 Nardoni S, Millants F, Mancianti F. (2000) In vitro sensitivity of two different inocula of microsporum canis versus terbinafine. J Mycol Med 10:14851.
17 Raubitschek F. (1961) Mechanical versus chemical keratolysis by dermatophytes. Sabouraudia 1:8790.[Medline]
18 Marro D, Guy RH, Delgado-Charro MB. (2001) Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release 70:21317.[CrossRef][Web of Science][Medline]
19 Dittmar W and Lohaus G. (1973) HOE 296, A new antimycotic compound with a broad antimicrobial spectrum. Arzneimittelforschung 23:6704.[Medline]
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Watanabe, C. Kawamura, Y. Masuda, Y. Akita, Y. Tamada, and Y. Matsumoto Successful Treatment of Toenail Onychomycosis With Photodynamic Therapy Arch Dermatol, January 1, 2008; 144(1): 19 - 21. [Full Text] [PDF] |
||||
![]() |
T. G. M. Smijs, J. A. Bouwstra, M. Talebi, and S. Pavel Investigation of conditions involved in the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment J. Antimicrob. Chemother., October 1, 2007; 60(4): 750 - 759. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





